Pharmacological therapy of ventricular arrhythmias;Medikamentose Therapie ventrikularer Arrhythmien

Medizinische Klinik

Volumn 92, Issue 4, 1997, Pages 208-210

  Hohnloser, Stefan H ^a,b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SOTALOL; ANTIARRHYTHMIC AGENT;

DRUG CONTRAINDICATION; DRUG INDICATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; PROGNOSIS; SHORT SURVEY; CLASSIFICATION; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART VENTRICLE TACHYCARDIA; REVIEW; SUDDEN DEATH;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HUMANS; SOTALOL; TACHYCARDIA, VENTRICULAR;

EID: 0030919966     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03043259     Document Type: Short Survey

References (11)

1. Connelly, S. J., M. Gent, R. S. Roberts et al.: Canadian Implantable Defibriliator Study (CIDS): study design and organization. Amer. J. Cardiol. 72 (1993), 103F-108F.
2. Echt, D. S., P. R. Liebson, L. B. Mitchell et al.: Mortality and morbidity in patients receiving encainide, flecainide on placebo. The Cardiac Arrhythmia Suppression Trial. New Engl. J. Med. 324 (1991), 781-788.
3. Moss, A. J., W. J. Hall, D. S. Cannom et al.: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. New Engl. J. Med. 335 (1996), 1933-1940.
4. Rogara, W. J., L. J. Bowlby, N. C. Chandra et al.: Treatment of myocardial infárction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation 90 (1994), 2103-2114.
5. Siebels, J., R. Cappato, R. Ruppel, M. A. E. Schneider, K. H. Kuck and the CASH Investigators: Preliminary results of Cardiac Arrest Study Hamburg (CASH). Amer. J. Cardiol 72 (1993), 109F-113F.
6. The AVID Investigators: Antiarrhythmics Versus Implantable Defibrillators (AVID). Rationale, design and methods. Amer. J. Cardiol. 75 (1995), 470-475.
7. The Cardiac Arrhythmia Suppression Trial II Investigators: Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. New Engl. J. Med. 327 (1992), 227-237.
8. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators: Preliminary on the reports effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New Engl. J. Med. 321 (1989), 406-412.
9. The CASCADE Investigators: Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study). Amer. J. Cardiol. 72 (1993), 280-287.
10. Waldo, A. L., A. J. Camm, H. de Ruyter, P. L. Friedman, D. J. MacNeil, J. F. Pauls, B. Pitt, C. M. Pratt, P. Schwartz, E. P. Veltri for the SWORD Investigators: Effect of d-Sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 348 (1996), 7-12.
11. Yusuf, S., R. Peto, J. Lewis, R. Collina, P Sleight: Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progr. cardiovasc. Dis. 77 (1985), 335-371.